Northern Light Pharmaceuticals AB
Innovative drugs for cancer, inflammatory pain, and neurological disorders
This article was originally published in Start Up
Executive Summary
Swedish start-up Northern Light Pharmaceuticals AB spun out of AstraZeneca AB with a portfolio of early-stage products designed to meet the aging population’s unmet needs in treating cancer, inflammatory pain, and neurological disorders.